BR0009445A - Utilização de um extrato lipìdeo-esterólico de serenoa repens - Google Patents

Utilização de um extrato lipìdeo-esterólico de serenoa repens

Info

Publication number
BR0009445A
BR0009445A BR0009445-5A BR0009445A BR0009445A BR 0009445 A BR0009445 A BR 0009445A BR 0009445 A BR0009445 A BR 0009445A BR 0009445 A BR0009445 A BR 0009445A
Authority
BR
Brazil
Prior art keywords
lipid
serenoa repens
sterolic
extract
manner
Prior art date
Application number
BR0009445-5A
Other languages
English (en)
Inventor
Pierre Fabre
Jean-Pierre Raynaud
Henri Cousse
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR0009445A publication Critical patent/BR0009445A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

"UTILIZAçãO DE UM EXTRATO LIPìDEO-ESTERóLICO DE SERENOA REPENS". A presente invenção apresenta a utilização de um extrato lipídeo-esterólico de Serenoa Repens para a fabricação de um medicamento destinado a ser administrado isoladamente ou em associação, de maneira simultânea, separada ou distribuída no tempo, com uma prostatectomia, uma radioterapia, e/ou uma hormonioterapia, visando a prevenção e/ou o tratamento do câncer da próstata.
BR0009445-5A 1999-03-30 2000-03-30 Utilização de um extrato lipìdeo-esterólico de serenoa repens BR0009445A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903959A FR2791573B1 (fr) 1999-03-30 1999-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
PCT/FR2000/000804 WO2000057892A1 (fr) 1999-03-30 2000-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate

Publications (1)

Publication Number Publication Date
BR0009445A true BR0009445A (pt) 2002-01-08

Family

ID=9543805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009445-5A BR0009445A (pt) 1999-03-30 2000-03-30 Utilização de um extrato lipìdeo-esterólico de serenoa repens

Country Status (15)

Country Link
US (1) US6599540B1 (pt)
EP (1) EP1165108B1 (pt)
JP (1) JP2003504306A (pt)
CN (1) CN1261142C (pt)
AT (1) ATE241375T1 (pt)
AU (1) AU774568B2 (pt)
BR (1) BR0009445A (pt)
CA (1) CA2370775C (pt)
DE (1) DE60003010T2 (pt)
DK (1) DK1165108T3 (pt)
ES (1) ES2199802T3 (pt)
FR (1) FR2791573B1 (pt)
MX (1) MXPA01009879A (pt)
PT (1) PT1165108E (pt)
WO (1) WO2000057892A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050159361A1 (en) * 2002-03-11 2005-07-21 Takahito Hara Remedies for sex hormone-dependent disease
JP5000525B2 (ja) 2004-11-25 2012-08-15 ザ ユニバーシティー オブ メルボルン 安定化したリン酸カルシウム複合体
AU2005316824B2 (en) * 2004-12-17 2012-05-31 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
ES2399345T3 (es) 2005-06-07 2013-03-27 The University Of Melbourne Mineralización dental
ES2530396T3 (es) 2005-06-24 2015-03-02 Univ Melbourne Complejos iónicos
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
AR059440A1 (es) 2006-02-09 2008-04-09 Univ Melbourne Composiciones con fluoruro y metodos para la mineralizacion dental
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296076A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Pueraria lobata Willd, Ohwi of the Leguminosae family and uses thereof
JP2010539085A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
US9155770B2 (en) * 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
AU2008296176A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
WO2009067555A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
WO2009067553A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
WO2009070478A2 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
AU2008326426A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
AU2009236339A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
JP2011519947A (ja) * 2008-05-06 2011-07-14 バイオノボ・インコーポレーテッド 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物
CA2726982A1 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositions
WO2009148620A2 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
WO2010012651A2 (en) * 2008-07-31 2010-02-04 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition useful for the prevention or reduction of the progression of prostate cancer
CA2734523A1 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer
US20100303936A1 (en) * 2009-04-28 2010-12-02 Bionovo, Inc. A Delaware Corporation Method of reducing fat accumulation and inducing weight loss
FR2963561B1 (fr) * 2010-08-03 2013-04-12 Pf Medicament Composition pharmaceutique contenant un extrait de serenoa repens
PL3024428T3 (pl) 2013-07-23 2021-07-05 The University Of Melbourne Kompozycje i sposoby mineralizacji zębów
EP3086751B1 (en) 2013-12-24 2023-07-12 The University Of Melbourne Stabilized stannous compositions
CZ306733B6 (cs) * 2014-08-27 2017-05-31 Walmark, A.S. Doplněk stravy na bázi klikvy velkoplodé pro použití k oddálení biochemického návratu karcinomu prostaty
JP7142943B2 (ja) 2017-03-14 2022-09-28 ザ ユニバーシティー オブ メルボルン 歯肉炎の処置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
FR2480754A1 (fr) * 1980-04-21 1981-10-23 Fabre Sa Pierre Procede d'obtention d'un extrait stable et desodorise de sabal serrulatum antiprostatique
IT1258305B (it) * 1992-04-10 1996-02-22 Zambeletti Spa L Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6107090A (en) * 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
DE69937564T2 (de) * 1998-08-03 2008-10-23 Ronald E. Sarasota Wheeler Prostata- formulierung
US6482447B2 (en) * 1999-09-10 2002-11-19 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6200573B1 (en) * 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia

Also Published As

Publication number Publication date
DK1165108T3 (da) 2003-09-22
US6599540B1 (en) 2003-07-29
CN1261142C (zh) 2006-06-28
AU3663100A (en) 2000-10-16
CA2370775C (fr) 2011-06-21
DE60003010T2 (de) 2004-04-01
FR2791573B1 (fr) 2003-04-11
JP2003504306A (ja) 2003-02-04
ATE241375T1 (de) 2003-06-15
EP1165108B1 (fr) 2003-05-28
CA2370775A1 (fr) 2000-10-05
MXPA01009879A (es) 2002-05-06
ES2199802T3 (es) 2004-03-01
AU774568B2 (en) 2004-07-01
PT1165108E (pt) 2003-10-31
CN1346277A (zh) 2002-04-24
WO2000057892A1 (fr) 2000-10-05
EP1165108A1 (fr) 2002-01-02
DE60003010D1 (de) 2003-07-03
FR2791573A1 (fr) 2000-10-06

Similar Documents

Publication Publication Date Title
BR0009445A (pt) Utilização de um extrato lipìdeo-esterólico de serenoa repens
IL134445A0 (en) A method of preventing or treating estrogen-dependent diseases and disorders
ATE307608T1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
BR0209147A (pt) Terapia combinada que usa anticorpos anti-egfr e agentes anti-hormonais
WO2001023405A3 (en) Therapeutic treatment of androgen receptor driven conditions
WO2001053836A3 (en) Identification, assessment, prevention, and therapy of prostate cancer
HUP0302544A2 (hu) Receptor tirozinkináz-gátlókat és vérérképződés-gátlókat alkalmazó kombinált terápia
BR0117063A (pt) Uso de ciclopamina no tratamento de carcinoma de células basais e outros tumores
IL155781A0 (en) Effective antitumor treatments
MY146533A (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
WO2002102306A8 (en) Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
MX2007006927A (es) Combinacion de inhibidor de tirosina cinasa y her-2/neu para terapia de cancer.
AU2020327022A8 (en) Method of treating cancer
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
MD1569G2 (ro) Metodă de tratament al cancerului mamar în perioada preoperatorie
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
BR0212446A (pt) Uso de 4-piridilmetilftalazinas para tratamento de câncer
WO2000004153A3 (en) Repression of cell transformation with human pea3
EP1161254A4 (en) TREATMENT OF AUTOIMMUNE DISEASES WITH AMERICAN GINSENG EXTRACT
IL164356A (en) Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer
DE59712247D1 (de) Mammakarzinom-assoziiertes gen
EP1385497A4 (en) METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN
UA34375A (uk) Спосіб лікування рака молочної залози

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/889 (2006.01), A61P 35/00 (2006.01)